Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4
Published January 21, 2026 · Recall initiated: November 26, 2025
Summary
FDA records drug Class III recall D-0257-2026, published January 21, 2026 and initiated November 26, 2025. Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC; Status: Ongoing; Lot: Lot#: AD30154, AD31143, AD31145, Exp 11/30/2025. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.
What to do
Voluntary: Firm initiated · Letter
Get an email if CLINDAMYCIN PHOSPHATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CLINDAMYCIN PHOSPHATE
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Distributor
- Nationwide in the USA.
- UPC
- 0351672408138
- Lot
- Lot#: AD30154, AD31143, AD31145, Exp 11/30/2025
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAClindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, RxSeptember 9, 2026
- FDAClindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL), 50 mL Single-Dose GALAXYSeptember 9, 2026
- FDAClindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container,September 9, 2026
- FDAClindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, RxSeptember 9, 2026
- FDAFluocinolone Acetonide Solution Topical Solution USP, 0.01%, 60-mL bottles, Rx only, Dist. by: TaroJanuary 21, 2026
- FDATESTO-100 CIII (testosterone 100 mg), 10 Sterile Pellets per carton, Rx only, Manufactured by: AdvancedJanuary 21, 2026
Questions about this recall
Was Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4 recalled?
Yes. FDA published recall D-0257-2026 on January 21, 2026. Reported hazard: Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CLINDAMYCIN PHOSPHATE. UPC: 0351672408138.